Burosumab for treating X-linked hypophosphataemia in children and young people

Highly specialised technologies guidance
Reference number: HST8
Published: 10 October 2018
Last updated: 20 September 2024

Evidence

Supporting evidence

Evaluation report
Final evaluation determination committee papers (PDF 4.29 MB)

Published:

10 October 2018
Evaluation consultation committee papers (PDF 27 MB)

Published:

10 October 2018